13 Jan Breast Cancer News from Medical News Today
[simple-rss feed="http://www.medicalnewstoday.com/rss/breastcancer.xml" limit=10]...
Cancer Research
11 Jul How metastasizing cancer cells enter organs
Posted at 23:48h
in Cancer Research
It is not primary tumors that are responsible for the majority of cancer deaths, but rather their metastases. Physiologists and neuropathologists from the University of Zurich have now identified the origin of metastasis formation, thereby becoming the first to reveal the pathway of metastasizing intestinal cancer cells out of the...
15 Jun Study: Virtual colonoscopy without laxative equals standard in identifying clinically significant polyps
Computed tomographic colonography (CTC), also known as virtual colonoscopy, administered without laxatives is as accurate as conventional colonoscopy in detecting clinically significant, potentially cancerous polyps, according to a study performed jointly at the San Francisco VA Medical Center, the University of California, San Francisco and Massachusetts General Hospital. "I think we...
04 May Blacks and Hispanics at Higher Risk for Precancerous Colorectal Polyps
Colonoscopy may be preferable to sigmoidoscopy for these populations Newswise — New York, NY (May 3, 2012) — Blacks and Hispanics have a significantly higher risk of developing precancerous colorectal polyps compared with whites, according to a study by researchers at NewYork – Presbyterian Hospital/Columbia University Medical Center. The findings appeared...
12 Apr Chemotherapy Proves Life-Saving for Some Leukemia Patients Who Fail Induction Therapy
Newswise — (MEMPHIS, Tenn. – April 11, 2012) An international study found that bone marrow transplants are not the best option for some young patients with acute lymphoblastic leukemia (ALL) who fail to attain clinical remission after the initial weeks of intense chemotherapy known as induction therapy. The largest study ever of...
28 Mar Intensity Modulated Radiation Therapy Reduces Risk of Side Effects in Breast Cancer Patients
Newswise — Breast cancer patients treated with intensity modulated radiation therapy (IMRT) instead of standard whole breast irradiation (WBI) have a lower incidence of acute or chronic toxicities, according to a study in Practical Radiation Oncology (PRO), the official clinical practice journal of the American Society for Radiation Oncology (ASTRO). Researchers...
28 Mar Report: New More-Sensitive Blood Test Catches Recurring Breast Cancer a Year Earlier
Posted at 20:55h
in Breast Cancer
Newswise — SAN DIEGO, March 28, 2012 Research was presented at a meeting of the American Chemical Society — A new blood test is twice as sensitive and can detect breast cancer recurrence a full year earlier than current blood tests, according to a scientist who reported here today at the...
28 Mar Report: US Cancer Death Rates Continue to Fall
Posted at 20:49h
in Cancer Research
Newswise — BOSTON—A report from the nation’s leading cancer organizations shows rates of death in the United States from all cancers for men and women continued to decline between 2004 and 2008. The findings come from the latest Annual Report to the Nation on the Status of Cancer. The report also...
15 Mar Dietary Cadmium May Be Linked with Breast Cancer Risk
Newswise — PHILADELPHIA — Dietary cadmium, a toxic metal widely dispersed in the environment and found in many farm fertilizers, may lead to an increased risk of breast cancer, according to a study published in Cancer Research, a journal of the American Association for Cancer Research. Cadmium occurs at low concentrations naturally,...
09 Mar Researchers reveal ways to make personalized cancer therapies more cost effective
AURORA, Colo. -- As scientists continue making breakthroughs in personalized cancer treatment, delivering those therapies in the most cost effective manner has become increasingly important. Now researchers at the University of Colorado School of Medicine have identified new ways of doing just that, allowing more patients to benefit from this...
09 Mar Study: Cancer of the Appendix is Different than Colon Cancer
WINSTON-SALEM, N.C. – March 7, 2012 – Researchers at Wake Forest Baptist Medical Center have demonstrated that cancer of the appendix is different than colon cancer, a distinction that could lead to more effective treatments for both diseases. The study by Edward A. Levine, M.D., professor of surgery and chief of...
06 Jan Study: Moderate red wine drinking may help cut women’s breast cancer risk
LOS ANGELES – Drinking red wine in moderation may reduce one of the risk factors for breast cancer, providing a natural weapon to combat a major cause of death among U.S. women, new research from Cedars-Sinai Medical Center shows. The study, published online in the Journal of Women's Health, challenges the...
08 Dec Risk for developing new cancer in other breast increased for survivors with BRCA mutation
Posted at 20:34h
in Breast Cancer
SAN ANTONIO — Breast cancer survivors who carry the BRCA1 or BRCA2 genetic mutation are at high risk for developing contralateral breast cancer — a new primary tumor in the other breast — and certain women within this group of carriers are at an even greater risk based on age...
08 Dec Many women do not undergo breast reconstruction after mastectomy
Posted at 20:31h
in Breast Cancer
SAN ANTONIO — Despite the benefits, only a small minority of women, regardless of age, are opting for immediate reconstructive breast surgery after undergoing mastectomy for treatment of breast cancer, according to data presented at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 6-10, 2011. Research has shown that...
08 Dec Low Risk Prostate Cancer: Panel endorses active monitoring
Posted at 19:59h
in Prostate Cancer
An independent panel convened this week by the National Institutes of Health has concluded that many men with localized, low-risk prostate cancer should be closely monitored, permitting treatment to be delayed until warranted by disease progression. However, monitoring strategies—such as active surveillance—have not been uniformly studied and available data do...
08 Dec Obese patients with HER2-positive breast cancer may have worse outcomes
SAN ANTONIO -- Obese patients with early-stage HER2-positive breast cancer may have worse outcomes than patients who are normal weight or overweight, Mayo Clinic researchers found in a study presented today at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium. HER2-positive breast cancer gets its name from a protein called...
08 Dec Judicious PSA, Testing, Can Help Reduce Unnecessary Prostate Biopsies
Posted at 19:49h
in Brigham & Women's - Harvard, Medical Research Centers, Prostate Cancer, University of Michigan
BOSTON – Prostate cancer screening that combines an adjusted blood test with other factors including the size of the gland, the patient’s overall weight and family history, can help up to one-quarter of men avoid biopsies and the risks associated with them, a Beth Israel Deaconess Medical Center-led research team...
20 Nov Researchers find genetic rearrangements driving 5 to 7 percent of breast cancers
Posted at 23:26h
in Breast Cancer, Cancer Research, Duke, Genetic Research, Nature, University of Michigan
ANN ARBOR, Mich. — Researchers at the University of Michigan Comprehensive Cancer Center have discovered two cancer-spurring gene rearrangements that may trigger 5 to 7 percent of all breast cancers. These types of genetic recombinations have previously been linked to blood cancers and rare soft-tissue tumors, but are beginning to be...
26 Oct Linking of mutations in 12 genes to ovarian cancer may lead to more effective prevention
Posted at 20:27h
in Ovarian Cancer
October 25 2011 More patients with ovarian carcinoma carry cancer-predisposing mutations, and in more genes, than previously thought. A rapid experimental method for screening genomes has located mutations in 12 genes for inherited cancers of the ovary, fallopian tubes and peritoneum (the thin tissue lining the lower abdomen). More than one-fifth of ovarian...
26 Oct Increase in postmastectomy breast reconstruction
Posted at 20:13h
in Breast Cancer
Released: 10/18/2011 11:00 AM EDT Source: American College of Surgeons (ACS) New findings show an increase in postmastectomy breast reconstruction, and that TRAM flap reconstruction remains intact with a high degree of patient satisfaction Newswise — SAN FRANCISCO: Until now, studies looking at trends in cancer care have shown that immediate postmastectomy breast...
26 Oct Through-the-Nipple Breast Cancer Therapy Shows Promise in Early Tests
October 26 2011 Newswise — Delivering anticancer drugs into breast ducts via the nipple is highly effective in animal models of early breast cancer, and has no major side effects in human patients, according to a report by Johns Hopkins Kimmel Cancer Center researchers in Science Translational Medicine on October 26....
26 Oct Gene responsible for relapses in young leukemia patients
One of the causes of resistance to cancer treatment in children is now beginning to be elucidated. Acute lymphoblastic leukemia patients with a particular form of the ATF5 gene are at higher risk of having a relapse when treated with E. coli asparaginase, a key chemotherapy drug for this type...
11 Oct Study shows increased prostate cancer risk from vitamin E supplements
Men who took 400 international units (I.U.) of vitamin E daily had more prostate cancers compared to men who took a placebo, according to an updated review of data from the Selenium and Vitamin E Cancer Prevention Trial (SELECT). The findings showed that, per 1,000 men, there were 76 prostate...
11 Oct Ovarian cancer patients survive longer with BRCA2 mutated in tumors
HOUSTON - Women with high-grade ovarian cancer live longer and respond better to platinum-based chemotherapy when their tumors have BRCA2 genetic mutations, researchers at The University of Texas MD Anderson Cancer Center and the Institute for Systems Biology report in the Oct. 12 issue of the Journal of the American...
11 Oct Mushroom compound appears to improve effectiveness of cancer drugs
AUGUSTA, Ga. – A compound isolated from a wild, poisonous mushroom growing in a Southwest China forest appears to help a cancer killing drug fulfill its promise, researchers report. The compound, verticillin A, sensitizes cancer cells to TRAIL, a drug which induces cancer cells to self destruct, said Dr. Kebin Liu,...
06 Oct Marijuana component could ease pain from chemotherapy drugs
A chemical component of the marijuana plant could prevent the onset of pain associated with drugs used in chemo therapy, particularly in breast cancer patients, according to researchers at Temple University's School of Pharmacy. The researchers published their findings, "Cannabidiol Prevents the Development of Cold and Mechanical Allodynia in Paclitaxel-Treated Female...
06 Oct Survival increased in early stage breast cancer after treatment with herceptin and chemo
Posted at 02:12h
in Breast Cancer
Treating women with early stage breast cancer with a combination of chemotherapy and the molecularly targeted drug Herceptin significantly increases survival in patients with a specific genetic mutation that results in very aggressive disease, a researcher with UCLA's Jonsson Comprehensive Cancer Center reported Wednesday. The study also found that a regimen...
06 Oct Tyk2 protein potential new Breast Cancer Therapy Target
New Rochelle, NY, October 5, 2011 -- A possible new target for breast cancer therapy comes from the discovery that the Tyk2 protein helps suppress the growth and metastasis of breast tumors, as reported in Journal of Interferon & Cytokine Research, a peer-reviewed journal published by Mary Ann Liebert, Inc. Qifang...
22 Sep Study reveals rise in prostate biopsy complications
Posted at 16:31h
in Prostate Cancer
In a study of complication rates following prostate biopsy among Medicare beneficiaries, Johns Hopkins researchers have found a significant rise in serious complications requiring hospitalization. The researchers found that this common outpatient procedure, used to diagnose prostate cancer, was associated with a 6.9 percent rate of hospitalization within 30 days...
22 Sep Cellular origin of a rare form of breast cancer identified
BOSTON (September 22, 2011) -- Identifying the cellular origins of breast cancer might lead to earlier diagnosis and more efficient management of the disease. New research led by Charlotte Kuperwasser of Tufts University School of Medicine (TUSM) has determined that common forms of breast cancer originate from breast cells known...